aQbD for OTC products

Solving Problems That Matter - a Waters webinar series featuring USP speakers

Episode 4: aQbD for OTC products

Summary

Analyzing over-the-counter formulations can be overwhelming due to the wide range of APIs and excipients used in varying concentrations. These excipients can cause problematic matrix effects and coelutions, making the analysis of formulations complex. Our panelists will discuss how to leverage aQbD software to develop a single chromatographic method suitable to analyze multiple APIs in a variety of formulations.

Key learning objective:

Learn how to leverage aQbD tools to develop a single method suitable for a variety of OTC formulations.

Who sould attend:

Pharmaceutical method developers

Presenter: Fadi Alkhateeb (Principle Scientist, Waters Corporations)

Dr. Fadi Alkhateeb is a Senior Scientist in the Scientific Operations Department at WatersCorporation HQ in Milford, MA USA. He joined Waters in 2017 and since then he has beenmainly focusing on exploring various approaches for analytical method development forpharmaceutical drugs. Prior to joining Waters, he was a postdoctoral fellow at the University ofCalgary (Calgary, AB, Canada), where he did research at Alberta Sulphur Research, one ofNorth America's leading Sulphur research institutes. He received his PhD from the University ofCalgary, focusing on the development of novel, rapid separation and sample preparationtechniques for the analysis of a wide range of chemical compounds. Dr. Alkhateeb publishedseveral peer-reviewed articles in top analytical journals.​

Moderated by: Isabelle Vu Trieu (Pharmaceutical Market Development Manager, Americas, Waters Corporation)

Isabelle is a business development professional dedicated to delivering benefits to analytical scientists in the life sciences industry. With over 20 years of experience in providing chromatography and mass spectrometry solutions, Isabelle is particularly interested in helping pharmaceutical scientists achieve the data quality and integrity needed to drive decisions for drug quality, safety and efficacy. Isabelle joined Waters in 2009 and currently manages the development of the pharmaceutical market in the Americas. She holds Masters’ degrees in Chemistry from Columbia University and the University Claude Bernard in Lyon, France as well as a Chemical Engineering degree from Ecole Supérieure de Chimie Physique Electronique in Lyon, France.